Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR. Fracture Intervention Trial. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000;85(11):4118–24.
Samelson EJ, Broe KE, Xu H, Yang L, Boyd S, Biver E, Szulc P, Adachi J, Amin S, Atkinson E, Berger C, Burt L, Chapurlat R, Chevalley T, Ferrari S, Goltzman D, Hanley DA, Hannan MT, Khosla S, et al. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. 2019;7(1):34–43.
Siris ES, Miller PD, Barrett-Connor E, et al. JAMA. 2001;286:2815–282.
Choksi P, Jepsen KJ, Clines GA. The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin Diabetes Endocrinol. 2018;4:12.
Hernandez CJ, van der Meulen MC. Understanding bone strength is not enough. J Bone Miner Res. 2017;32(6):1157–62. Interesting review showing bone strength is not enough to explain bone.
Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29(1):1–23. This a very interesting report that summarizes the current knowledge about atypical fractures, in particular during antiresorptives therapy.
Zanchetta MB, Diehl M, Buttazzoni M, Galich A, Silveira F, Bogado CE, Zanchetta JR. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur. J Bone Miner Res. 2014;29(4):999–1004. This interesting shows that assessment of bone microarchitecture is not enough to comprehensively identify patients at risk for atypical fractures. This highlights the need to identify a novel mechanism responsible for this type of fracture.
Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383(8):743–53.
Kostenuik PJ, Smith SY, Samadfam R, Jolette J, Zhou L, Ominsky MS. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys. J Bone Miner Res. 2015;30(4):657–69.
Törring O. Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis. Ther Adv Musculoskelet Dis. 2015;7(3):88–102.
Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black DM. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008;23(12):1974–82.
Zebaze R, Libanati C, McClung MR, Zanchetta JR, Kendler DL, Høiseth A, Wang A, Ghasem-Zadeh A, Seeman E. Denosumab reduces cortical porosity of the proximal femoral shaft in postmenopausal women with osteoporosis. J Bone Miner Res. 2016;31(10):1827–34.
Andika GD, Nugraha GKAS, Sunaria IM, Astawa P, Wiratnaya IGE, Maharjana MA. Pathological fracture of subtrochanter femur, soft tissue infection along the fracture site, shaft femur bone cortex thickening and blastic lesion on contralateral shaft femur due to renal osteodystrophy on the end stage renal disease patient: a case report. Int J Res Med Sci. 2020;8:3715–9.
Nijhuis WH, Eastwood DM, Allgrove J, Hvid I, Weinans HH, Bank RA, Sakkers RJ. Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management. J Child Orthop. 2019;13(1):1–11.
Villa-Suárez JM, García-Fontana C, Andújar-Vera F, González-Salvatierra S, de Haro-Muñoz T, Contreras-Bolívar V, García-Fontana B, Muñoz-Torres M. Hypophosphatasia: a unique disorder of bone mineralization. Int J Mol Sci. 2021;22(9):4303.
Black DM, Bauer DC, Vittinghoff E, Lui LY, Grauer A, Marin F, Khosla S, de Papp A, Mitlak B, Cauley JA, McCulloch C, Eastell R, Bouxsein ML, Foundation for the National Institutes of Health Bone Quality Project. Foundation for the National Institutes of Health Bone Quality Project. Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials. Lancet Diabetes Endocrinol. 2020;8(8):672-682.
Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, Mackie EJ, Seeman E. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010;375(9727):1729–36.
Allen D, Schriever WR. Progressive collapse, abnormal loads and building codes. In: Structural failures: modes, causes, responsibilities. New York, NY: American Society of Civil Engineers; 1973. p. 21–48.
Di Cataldo S, Ficarra E. Mining textural knowledge in biological images: applications, methods and trends. Comput Struct Biotechnol J. 2016;15:56–67. https://doi.org/10.1016/j.csbj.2016.11.002.
Schousboe JT, Vo T, Taylor BC, Cawthon PM, Schwartz AV, Bauer DC, Orwoll ES, Lane NE, Barrett-Connor E, Ensrud KE, for the Osteoporotic Fractures in Men (MrOS) Study Research Group. Prediction of incident major osteoporotic and hip fractures by Trabecular Bone Score (TBS) and prevalent radiographic vertebral fracture in older men. J Bone Miner Res. 2016;31(3):690–7. https://doi.org/10.1002/jbmr.2713.
Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C, Zheng MH. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013;15:223.
Guilak F. Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol. 2011;25(6):815–23.
Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C, Zheng MH. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013;15:223.
Beck C, Morbach H, Wirth C, Beer M, Girschick HJ. Whole-body MRI in the childhood form of hypophosphatasia. Rheumatol Int 2011; 31:1315–1320.
Sun HB. Mechanical loading, cartilage degradation, and arthritis. Ann N Y Acad Sci. 2010;1211:37–50.
Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone. 2016;86:119–30.
Zhu J, Zhu Y, Xiao W, Hu Y, Li Y. Instability and excessive mechanical loading mediate subchondral bone changes to induce osteoarthritis. Ann Transl Med. 2020;8(6):350.
Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328.
Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, Yue Y, Qian W, Li L. NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev. 2020;2020:4063562–11.
Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, Goodman SB. Modulation of the inflammatory response and bone healing. Front Endocrinol (Lausanne). 2020;11:386.
Nencini S, Ivanusic JJ. The physiology of bone pain. How much do we really know? Front Physiol. 2016;7:157.
Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res. 1999;14(10):1654–63.
Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res. 1988;232:210–6.
Temponi EF, de Carvalho Junior LH, Costa LP. Atypical femoral fracture due to chronic use of bisphosphonates: case report. Rev Bras Ortop. 2015;50(4):482–5.
Gregory DR, Sui LK, Hans-Christoph P. Periprosthetic fractures: epidemiology and future projections. J Orthop Trauma. 2011;25:S66–70.
El Demellawy D, Davila J, Shaw A, Nasr Y. Brief review on metabolic bone disease. Acad Forensic Pathol. 2018;8(3):611–40.
Sato H, Kondo N, Wakamatsu A, Kobayashi D, Nakatsue T, Wada Y, Kuroda T, Suzuki Y, Nakano M, Endo N, Narita I. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan. Rheumatol Int. 2019;39(10):1803–10.
Koh JH, Myong JP, Jung SM, Lee J, Kwok SK, Park SH, Ju JH. Atypical femoral fracture in rheumatoid arthritis patients treated with bisphosphonates: a nested case-control study. Arthritis Rheumatol. 2016;68(1):77–82.
Oh D, Huh SJ. Insufficiency fracture after radiation therapy. Radiat Oncol J. 2014;32(4):213–20. https://doi.org/10.3857/roj.2014.32.4.213.
Celii FG, Beckmann NM. Radiation-induced insufficiency fracture of the femur 18 years after radiation therapy. Radiol Case Rep. 2018;14(2):179–83.
Howland WJ, Loeffler RK, Starchman DE, Johnson RG. Post irradiation atrophic changes of bone and related complications. Radiology. 1975;117(3 Pt 1):677–85.
Pastores GM, Einhorn TA. Skeletal complications of Gaucher disease: pathophysiology, evaluation, and treatment. Sem Hematol. 1995;32(Suppl 1):20–7.
van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy. 2012;67(3):431–8.
Hughes RA. Arthritis precipitated by isotretinoin treatment for acne vulgaris. J Rheumatol. 1993;20(7):1241–2.
Krebs NM, Krebs RC, Yaish AM. Femoral osteomyelitis presenting as a pathologic fracture in a 53-year-old male: a rare case report. J Orthop Case Rep. 2017;7(6):85–8. https://doi.org/10.13107/jocr.2250-0685.962.
Bouchette P, Boktor SW. Paget disease. 2021 Jul 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.
Appelman-Dijkstra NM, Papapoulos SE. Paget’s disease of bone. Best Pract Res Clin Endocrinol Metab. 2018;32(5):657–68.
Sepehri NZ, Raeisi T, Razi B, Janmohammadi P, Darand M, Alizadeh S. The association between psoriasis and psoriatic arthritis with the risk of osteoporosis, osteopenia and bone fractures: a systematic review and meta-analysis. Int J Clin Pract. 2021;75(11):e14630.
Caffarelli C, Gonnelli S, Tomai Pitinca MD, Francolini V, Fui A, Bargagli E, Refini RM, Bennett D, Nuti R, Rottoli P. Idiopathic pulmonary fibrosis a rare disease with severe bone fragility. Intern Emerg Med. 2016;11(8):1087–94.
Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S, Visalli E, Bagnato G. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS ONE. 2013;8(6):e66991.
Beck BR, Daly RM, Singh MA, Taaffe DR. Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis. J Sci Med Sport. 2017;20(5):438–45.
Limaiem F, Byerly DW, Singh R. Osteoblastoma. 2022 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Wordsworth P, Chan M. Melorheostosis and osteopoikilosis: a review of clinical features and pathogenesis. Calcif Tissue Int. 2019;104:530–43.
留言 (0)